NexImmune has filed a notice of a Private Investment in Public Equity (PIPE) offering of securities to raise $3,670,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, NexImmune is raising $3,670,000.00 in new funding. About NexImmune: NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with…